- Home
- NERV vs CETY Comparison
NERV vs CETY Comparison
Compare NERV & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CETY
- Stock Information
- Founded
- NERV 2007
- CETY 1993
- Country
- NERV United States
- CETY United States
- Employees
- NERV N/A
- CETY N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CETY Power Generation
- Sector
- NERV Health Care
- CETY Utilities
- Exchange
- NERV Nasdaq
- CETY Nasdaq
- Market Cap
- NERV 14.6M
- CETY 12.2M
- IPO Year
- NERV 2014
- CETY N/A
- Fundamental
- Price
- NERV $3.78
- CETY $2.04
- Analyst Decision
- NERV Hold
- CETY
- Analyst Count
- NERV 1
- CETY 0
- Target Price
- NERV $4.00
- CETY N/A
- AVG Volume (30 Days)
- NERV 101.0K
- CETY 17.6M
- Earning Date
- NERV 11-05-2025
- CETY 11-19-2025
- Dividend Yield
- NERV N/A
- CETY N/A
- EPS Growth
- NERV N/A
- CETY N/A
- EPS
- NERV N/A
- CETY N/A
- Revenue
- NERV N/A
- CETY $2,282,095.00
- Revenue This Year
- NERV N/A
- CETY N/A
- Revenue Next Year
- NERV N/A
- CETY N/A
- P/E Ratio
- NERV N/A
- CETY N/A
- Revenue Growth
- NERV N/A
- CETY N/A
- 52 Week Low
- NERV $1.15
- CETY $1.05
- 52 Week High
- NERV $12.46
- CETY $11.25
- Technical
- Relative Strength Index (RSI)
- NERV 49.13
- CETY 59.18
- Support Level
- NERV $3.76
- CETY $1.05
- Resistance Level
- NERV $4.42
- CETY $2.98
- Average True Range (ATR)
- NERV 0.32
- CETY 0.27
- MACD
- NERV -0.09
- CETY 0.07
- Stochastic Oscillator
- NERV 25.93
- CETY 50.26
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.